Takashi Sato

Has grant

Junior Associate Professor

Kitasato University School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

肺がんの進展・適応過程における可塑性に関する研究

Open Date: 2021-04-01

Close Date: 2022-03-01

Grant: Close

肺がんにおける分化プログラムの不均一性と可塑性の解明

Open Date: 2021-01-01

Close Date: 2022-12-01

Grant: Close

Exploration of differentiation programs in lung cancers using epigenomic profiling

Open Date: 2020-04-01

Close Date: 2023-03-01

Grant: Close

肺がんのフェノタイプを規定する分化プログラムの不均一性・可塑性の解明

Open Date: 2020-04-01

Close Date: 2021-03-01

Grant: Close

Research Fellowship Program

Open Date: 2017-04-01

Close Date: 2018-03-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Jun Zhu

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

CHARLES POWELL

Division Chief/Professor of Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takashi Sato

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

The Glasgow prognostic score predicts survival in patients with advanced non-small cell lung cancer harboring sensitive EGFR mutations who are treated with EGFR tyrosine kinase inhibitors

Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma

The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer

Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation

First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study

Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression

Successful Tepotinib Challenge After Capmatinib-Induced Interstitial Lung Disease in a Patient With Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation: Case Report

Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy

Collaborators (2)

Jun Zhu

CHARLES POWELL

Make your next move.